Age (mean±SD) |
32 ± 17 |
Male sex (n, %) |
9 (45) |
Previous pacemaker (n, %) |
10 (50) |
Previous cardiac surgery (n, %) |
15 (75) |
LV systemic ventricle (n, %) |
14 (70) |
RV systemic ventricle (n, %) |
6 (30) |
LV systemic ventricle EF (%)(mean±SD) |
51±16 |
RV systemic ventricle FAC (%) (mean±SD) |
39±13 |
Systemic ventricle systolic dysfunction (n, %) |
13 (65) |
Baseline QRS width (mean±SD) |
144±32 |
Baseline QRS>120 ms (n, %) |
14 (70) |
NYHA functional class (n, %)
- I
- II
- III/IV
|
11 (55)
9 (45)
0
|
Baseline rhythm at implant (n, %)
- normal AV conduction
- 2nd degree AV block
- complete AV block
|
3 (15)
2 (10)
15 (75)
|
Atrial arrhythmias (n, %) |
10 (50) |
Oral anticoagulation (n, %) |
7 (35) |
Serum creatinine (mean±SD) |
0.76±0.21 |
INR (mean±SD) |
1.3±0.5 |
General anesthesia (n, %) |
4 (20) |
Total procedure time (min)(mean±SD) |
126±82 |
CSP lead implant time (mean±SD) |
31±28 |
CSP sheath (n, %)
- C315His
- C304
- Other
|
14 (70)
4 (20)
2 (10)
|
No. attempts for CSP lead implant (mean±SD) |
3.4±2.8 |
No. turns to screw the CSP lead (mean±SD) |
14±6 |
CSP lead pacing threshold (V)(mean±SD) |
0.85±0.61 |
CSP lead sensing (mV) (mean±SD) |
9.8±9.2 |
CSP lead pacing impedance (Ohms)(mean±SD) |
735±253 |
Final paced QRS width (ms)(mean±SD) |
116±16 |
Total fluoroscopy time (min) (mean±SD) |
27±30 |